2020.06.22
License Agreement has been entered into with Anatomic Incorporated
License-Out
We have executed a non-exclusive license agreement with Anatomic Incorporated (Minneapolis, MN, U.S.A.). With this license, Anatomic will be manufacturing iPS cell-derived neural tissues for disease modeling and drug screening. Anatomic will serve its end users by offering these tissues for sale, as well as offering services related to these core competencies for user's research purposes under the patents on iPS cell technologies licensed to us by Kyoto University.